department of pathology gadjah mada university school of ... dasar neoplasia blok biomedis... ·...
TRANSCRIPT
TUMSO3O3O9 1
Department of PathologyGadjah Mada University School of Medicine
Blok Biomedis, 4 Maret 2009 [11]
Neoplasia• Neoplasia new growth
• Neoplasm: abnormal tissue mass growing excessively and indefinitely without coordination with normal tissue
TUMSO3O3O9 2
coordination with normal tissue
• Behaviour: progressive, useless, independent from surrounding tissue, unrelated to host needs, parasitic, autonomic.
NEOPLASIA(BASIC SCIENCES OF ONCOLOGY)
GENERAL DIAGNOSIS
COMPREHENSION
TUMSO3O3O9 3
EPIDEMIOLOGY THERAPY
PATHOBIOLOGY MANAGEMENT
NEOPLASIA• General Comprehension of Cancer
Definition, Perspective, Nomenclature, Epidemio-logy, Hereditary Pre-neoplastic Disease
• The Pathobiology of cancer
TUMSO3O3O9 4
Molecular Basis of Cancer, Oncogenes, Apoptotic Genes, Suppressor Genes, Telomerase, Epige-netic Theory
• The Clinical Relevancies of CancerBiology of Tumor Growth, The Kinetic of Tumor, Immunology of Tumor, Clinical Features of Tumor
Related terms
• Hypertrophy• Hyperplasia• Metaplasia
TUMSO3O3O9 5
• Metaplasia• Displasia• Anaplasia
• HAMARTOMA
• Hiperplasia: an increase in the number of cells in an organ/ tissue
• Hipertrofi: an increase in the size of the cells
• Metaplasia : a reversible change in which one adult cell type is replaced by another adult cell type
ISTILAH YANG BERUBUNGAN DENGAN NEOPLASIA
TUMSO3O3O9 6
cell type is replaced by another adult cell type
• Displasia: a loss in the uniformity of the individual cells + a loss of their architectural orientation
• Anaplasia: lack of differentiation
• Hamartoma: tumor like lesion, consist of two/ more mature cell type normally found in an organ in which the lesion arises
Metaplasia
TUMSO3O3O9 7
Apocrine metaplasia of the breast Squamous metaplasia
Diferensiasi
• Suatu proses/keadaan/perkembangan sel tumor sampai tingkat tertentu di mana ada kemiripan sel-sel neoplastik dengan sel asalnya (baik, sedang, buruk tanpa
TUMSO3O3O9 8
asalnya (baik, sedang, buruk tanpa diferensiasi / anaplasi)
Anaplasia:
- pleomorfisma selular dan nuklear- peningkatan rasio inti/sitoplasma- meningkatnya kromatin inti clumping /
TUMSO3O3O9 9
- meningkatnya kromatin inti clumping / irregular
- mitosis patologik bizarre- hilangnya orientasi (polarisasi sel)- hilangnya kapasitas fungsional sel
Dysplasia
TUMSO3O3O9 10
History – 1
Cancer has become increasingly prominent in modern time
Cancer is not a modern disease
TUMSO3O3O9 11
Cancer is not a modern disease
recorded in ancient civilization: mummies from Egypt,
Ramayana history (2500 BC)
• early cultures attributed the cause of cancer
to various gods
History – 2
ancient civilization
middle agesHippocrates: ~400BC 1st theory
of natural causes of cancer: imbalance between
TUMSO3O3O9 12
of natural causes of cancer: imbalance between black humor and the three bodily humors: blood,
phlegm, bile
Cancer house, cancer family, cancer village
History – 3Sir Percival Pott (1775)
(the 1st recorded epidemiological study of cancer)
Young boy as a chimney sweeps In their twentieth had a high rate of death due to cancer of the scrotum then
TUMSO3O3O9 13
high rate of death due to cancer of the scrotum then
he suggested frequent washing and changing of clothing that trapped the soot reduce exposure to “carcinogen”
Other epidemiological study – identified major environmental factors: tobacco smoke, various
occupational exposure
History – 4Invention of microscope
Virchow every cell is born from another cell cancer is a cellular disease
Cell biology molecular genetics the advancement of
TUMSO3O3O9 14
Cell biology molecular genetics the advancement of knowledge about cancer biology cancer is
a genetic disease
Diagnostic, prognostic factors, therapy depend on the study of populations of patients
History – 5Population study of cancer patients
Recognize the presence of heterogeneity
among patients with certain tumors
Predict the probability of certain outcome (e.g. survival as function of time), based on the properties of tumors and host
TUMSO3O3O9 15
time), based on the properties of tumors and host
Challenge in therapeutic studies: application of knowledge about:
produce overall improvements in treatment outcome
with acceptable level of toxicity
The biology of tumor
Normal cells
Malignant cells
TUMSO3O3O9 16
Changes:• Genotypic
• Phenotypic
Nomenklatur (tatanama)
Awalan yang menunjukkan asal jaringan
Skuamosa (epitel gepeng berlapis), adeno-(epitel kelenjar), transisional, fibro- (jaringan ikat fibrosa, leiomio-(otot polos), rabdomio-(otot lurik), lipo-(lemK), kondro (tulang rawan), osteo-(tulang), hemangio-(pembuluh darah), limfangio-(pembuluh limfe)
Awalan yang menunjukkan pola pertumbuhan
TUMSO3O3O9 17
Awalan yang menunjukkan pola pertumbuhan
Folikular, sistik, papilar, vilosa, kribriformis, dll.
Kata tambahan menunjukkan gambaran makroskopik
Scirrhous (keras), medular (lunak, menyerupai sumsum tulang), koloid)
Teratoma
Berasal dari lebih dari satu germ layer (jinak & ganas)
Benign epithelial tumors
TUMSO3O3O9 18
Adenomatous polyp
Benign germ cell tumors
TUMSO3O3O9 19
Benign cystic teratoma (dermoid cyst)
Benign epithelial tumor
TUMSO3O3O9 20
Squamous cell Papilloma
Benign epithelial tumor
TUMSO3O3O9 21
Fibroadenoma of the breast
Benign epithelial tumor
TUMSO3O3O9 22
Pleomorphic Adenoma of the salivary gland
Benign vs malignant epithelial tumor
TUMSO3O3O9 23
Adenoma Adenocarcinoma
Malignant epithelial tumor
TUMSO3O3O9 24
Carcinoma of the breast
Malignant tumor
TUMSO3O3O9 25
Cystadenocarcinoma of the ovari
Malignant epithelial tumor
TUMSO3O3O9 26
Squamous cell carcinoma
Malignant Epithelial Tumors
TUMSO3O3O9 27
Carcinoma in situ of the uterine cervix
Malignant epithelial tumor
TUMSO3O3O9 28
Colon carcinoma
Malignant Epithelial Tumors
Well differentiated
TUMSO3O3O9 29
Well differentiated adeno-carcinoma of the colon
Benign germ cell tumors
TUMSO3O3O9 30
Benign cystic teratoma (dermoid cyst)
Malignant mesenchymal tumor
TUMSO3O3O9 31
Rhabdomyosarcoma
Principal characteristics of benign and malignant tumors
Features Benign Malignant
Growth rate Slow Relatively rapid
Mitotic activity Low High
Histologic resemblance to normal tissue
Good Variable, often poor
Nuclear morphology Mostly normal Hyperchromatic,multiple nucleoli, pleomorphic
TUMSO3O3O9 32
Invasion No Yes
Metastasis never Frequent
Border Circumscribed/ encapsulated
Poorly defined/ irregular
Necrosis Rare Common
Ulceration Rare Common
Growth Often exophytic Often endophytic
Malignant Mesenchymal Tumors
TUMSO3O3O9 33
Rhabdomyosarcoma
Benign vs malignant
• Benign malignant
Circumscribed/ encapsulated
Intact surface
Exophytic growth
Ulcerated surfaceEndophytic growth
TUMSO3O3O9 34
Circumscribed/ encapsulated
Homogenous cut surface Heterogenous cut surface due to necrosis
Vascular permeation
Irregular infiltrative edge
Benign vs Malignant Tumors
TUMSO3O3O9 35
Benign vs malignant
TUMSO3O3O9 36
Benign vs malignant mesenchymal tumor
TUMSO3O3O9 37
Leiomyoma of the uteri
Spread of Malignant Tumors
TUMSO3O3O9 38
Metastatic cancer in the liver (pancreatic adenocarcinoma)
Cystic lesion of the breast
TUMSO3O3O9 39
Metastasis
1. Limfogen2. Hematogen
- Sistem venas porta hati- Sistem venosa sistemik paru- Sistem vena paru jantung kiri sirkulasi umum
TUMSO3O3O9 40
- Sistem vena paru jantung kiri sirkulasi umum- Ca uteri & abdomen limfonodi cisterna chyli ductus thoracicus sistemik
3. Trans-coelomic4. Intra-epitelial
The Pathobiology of Cancer
Molecular basis of cancer: Oncogenes and regulator genes
Carcinogenic agents and their cellular interaction: chemical, radiation, viral, bacterial carcinogenesis
Biology of tumor growth: kinetic, angiogenesis, progression and heterogeneity, invasion and metastasis
TUMSO3O3O9 41
and heterogeneity, invasion and metastasis
Host defense against tumors: tumor antigens and immunosurveillance
Clinical features of tumors: efect of tumors on host grading and staging of tumors
Epidemiologi : Faktor risiko
1. UmurMakin tua pengaruh karsinogen makin kuat
2. DietPerbedaan geografis insiden kanker mencerminkan perbedaan diet
TUMSO3O3O9 42
perbedaan dietMinuman alkohol berpengaruh terhadap karsinogenesis
3. LingkunganPolusi (rokok, pekerjaan, kendaraan, pabrik)Ativitas seksual
4. Perubahan genetik
Cancerepidemiology
TUMSO3O3O9 43
Comparison between native Japanese, Japanese immigrants and Calif.white
TUMSO3O3O9 44
HEREDITY & CANCER
Question:Is cancer inherited?
Evidence:Lung cancer in most instances clearly related to
TUMSO3O3O9 45
Lung cancer in most instances clearly related to cigarette smoking, yet,
mortality to lung cancer has been shown to be four times greater among non-smoking relatives
(parents & siblings) of lung cancer patients than non-smoking relatives of controls
Hereditary forms of cancers canbe divided into 3 categories:
1. Inherited Cancer Syndromes (autosomal dominant)
TUMSO3O3O9 46
2. Familial Cancers3. Autosomal Recessive Syndromes of
Defective DNA Repair
1. Inherited Cancer Syndromes (autosomal dominant)
• Inheritance of a single mutant gene greatly increases the risk of developing a tumor
• The predisposition of these tumors shows an
TUMSO3O3O9 47
• The predisposition of these tumors shows an autosomal dominant pattern of inheritance
• Inherited predisposition is indicated by strong family history of uncommon cancer and/or associated marker phenotype
1. Inherited Cancer Syndromes (autosomal dominant)
Contoh tumor• Familial retinoblastoma• Familial adenomatous polyposis
TUMSO3O3O9 48
• Familial adenomatous polyposis of the colon
• Multiple endocrine neoplasia syndromes (MEN)
• Neurofibromatosis type 1 and 2• Von Hippel–Lindau Syndromes
Inherited Cancer Syndromes
RETINOBLASTOMA• Carriers of mutant Rb
gene have a 10,000 fold increased risk of
TUMSO3O3O9 49
increased risk of developing retinoblastoma (familial type)
• greatly increased of developing second cancer (ostreosarcoma)
Inherited Cancer Syndromes
Multiple endocrine neoplasia (MEN)- The familial occurrence of the combination of:
medullary thyroid Ca, bilateral pheochromocy-tomas, hyperparathyroidism (due to tumor)
TUMSO3O3O9 50
tomas, hyperparathyroidism (due to tumor)- Mutation of ret proto-oncogene that is transmitted
in the germline
Inherited Cancer Syndromes
Von Recklinghausen neurofibromatosis type 1 and 2- multiple benign neurofibromas, cafe au laitspot, iris hamartoma, increased risk of
TUMSO3O3O9 51
spot, iris hamartoma, increased risk of developing fibrosarcomas
- mutation of NF-1 and NF-2 (tumor suppressorgenes which functions as a GAP protein that inactivates ras)
Familial Adenomatous Polyposis Coli• Another hereditary disorder marked by
an extraordunarily high risk of cancer
Inherited Cancer Syndromes
TUMSO3O3O9 52
an extraordunarily high risk of cancer • Autosomal dominant mutation from
birth innumerable polypoid adenomas mostly develop colon Ca by age of 50
Adenoma-Carcinoma Sequence
TUMSO3O3O9 53
Inherited Cancer Syndromes
Von Hippel-Lindau Syndrome
• Germ line mutation of VHN gene on chromosome 3p hereditary renal cell
TUMSO3O3O9 54
chromosome 3p hereditary renal cell cancer, phaeochromocytoma, hemangioblastoma of the CNS, retinal angioma, renal cyst
2. Familial Cancers
Evident familial clustering of cancer but role of inherited predisposition may not be clear in an individual case
TUMSO3O3O9 55
– Breast Cancer
– Ovarian cancer
– Colon cancer other than familial adenomatous polyps
3. Autosomal Recessive Syndromes of Defective DNA Repair
Xeroderma pigmentosum
Ataxia telangiectasia
TUMSO3O3O9 56
Ataxia telangiectasia
Bloom syndrome
Fancony anemia
- autosomal recessive disorder hypersensitive to UV
Xeroderma pigmentosum
Autosomal Recessive Syndromes of Defective DNA Repair
TUMSO3O3O9 57
- increased incidence of skin cancers- defect in genes that function in nucleotide
excision repair, which is required for repair of UV-induced pyrimidine dimers
Autosomal Recessive Syndromes of Defective DNA Repair
Ataxia Telangiectasia AT gene (mutation in single gene)
– Gradual loss of Purkinje cells
TUMSO3O3O9 58
– Immunodeficiency
– Acute sensitivity to ionizing radiation
– Profound susceptibility to lymphoid malignancies
Autosomal Recessive Syndromes of Defective DNA Repair
Bloom Syndrome• Hypersensitivity to ionizing
TUMSO3O3O9 59
• Hypersensitivity to ionizing radiation
• Developmental defects
• Predisposition to cancer
Autosomal Recessive Syndromes of Defective DNA Repair
Fanconi anemia• Hypersensitivity to DNA cross-
linking agents (nitrogen mustard)
TUMSO3O3O9 60
linking agents (nitrogen mustard)
• Anemia
• Predisposition to cancer
Acquired Pre–neoplastic Disorders
• Cell replication is involved in cancerous transformation
• Fertile soil for the origin of malignant neoplasm:- regenerative proliferation: hepatoma- hyperplasia: endometrium
TUMSO3O3O9 61
- hyperplasia: endometrium- dysplasia: cervical- metaplasia: bronchogenic Ca
the risk to develop neoplasm isgreater than average
• Certain non-neoplastic disorder pre-neoplastic
- chronic atrophic gastritis
- solar keratosis
Acquired Pre–neoplastic Disorders
TUMSO3O3O9 62
- solar keratosis
- leukoplakia
The great majority of instances no malignant neoplasm emerges the term persists because it calls attention to the increased risk
The question then …….
Is there any risk with all benign neoplasms?
• although some risk may be inherent, most benign neoplasm neoplasms do not become cancerous.
• Some malignant tumors were developed from benign tumors: leiomyoma leiomyosarcoma, pleomorphic adenoma Ca
TUMSO3O3O9 63
Was the tumor an indolent form of cancer from the outset, or was there a malignant focus in the benign tumor?
• Generalization is impossible because each type of benign neoplasm is associated with a particular level of risk ranging from almost zero to frequently present
PATOGENESIS KANKER
• Faktor geografik dan lingkungan
• Umur
TUMSO3O3O9 64
• Umur
• Predisposisi genetik
• Predisposisi non-herediter
Bacteria?
TUMSO3O3O9 65
CARCINOGENESIS
The Molecular basis of Cancer
• Jantung permasalahan karsinogenesis: kerusakan genetik non-letal
• Tumor terbentuk dengan eksansi klonal sel
TUMSO3O3O9 66
• Tumor terbentuk dengan eksansi klonal sel prekursor tunggal akibat dari kerusakan genetik
• Karsinogenesis adalah suatu proses multistep pada tingkat genetik dan fenotipik sekaligus
CARCINOGENESIS
The Molecular basis of Cancer
• 4 kelas gena regulator normal (target utama kerusakan genetik): (1) growth promoting protooncogenes, (2) antioncogenes (growth inhibiting suppressor genes), (3) apoptotic genes (mengatur programmed cell death), dan
TUMSO3O3O9 67
genes (mengatur programmed cell death), dan (4) gena reparasi DNA
• Gena reparasi DNA mempengaruhi proliferasi sel dan survival secara tidak langsung dengan kemampuan reparasi kerusakan non letal gena lain, termasuk gena-gena replikasi sel.
Perubahan fenotipik• Sifat pertumbuhan
- lepas dari kontrol- kegagalan maturasi- transplantable- immortal
TUMSO3O3O9 68
- immortal• Perubahan morfologik• Kariotipik• Antigenik• Deviasi metabolik• Membran sel
AKTIVASI ONOGENA
Mekanisma perubahan protoonkogena menjadi onkogena
• Perubahan struktur gena prodk gena abnormal (onkoprotein) - Mutasi titik
TUMSO3O3O9 69
- Insersi dan delesi• Perubahan regulasi: expresi gena meningkatkan
produksi berlebihan protein perangsang pertumbuhan (growth-promoting protein)- translokasi kromosom- amplifikasi gena
Mutasi titik• ras oncogene the best example
• A very large number of human tumors carry ras point-mutations
• Mutation affect a domain critical to the GAP-induced hydrolysis of GTP mutant ras proteins have a reduced ability to hydrolyze GTP
TUMSO3O3O9 70
ability to hydrolyze GTP
• Frequency:
- 90%: pancreatic adenocarcinoma
- 50%: colon and thyroid cancer
- 30%: lung adenocarcinoma & myeloid leukemia
- 0%: most ovarian and breast tumors
Chromosomaltranslocations
Burkitt’s lymphoma
TUMSO3O3O9 71
Chronic Myelogenous Leukemia
GeneAmplification
TUMSO3O3O9 72
• Amplification of N-myc gene in neuroblastoma: double minutes / HSR (Homogenous-staining region)
CANCER SUPPRESSOR GENES
• Misnomer
• Physiologic function: regulate cell growth
apply brakes to cell proliferation
TUMSO3O3O9 73
apply brakes to cell proliferation
• Discovered by studying rare disease such as retinoblastoma
• Knudson “two-hit” hypothysis of oncogenesis
Sub-cellular location of protein product of tumor suppressor genes
2 broad categories regarding the functions:Molecules that regulate nuclear transcription and cell
cycle• Cell surface: TGF-receptor, E-cadherin• Under plasma mebrane: NF-1
TUMSO3O3O9 74
• Under plasma mebrane: NF-1• Cytoskeleton: NF-2• Cytosol: APCMolecules that regulate signal tranduction• Nucleus: Rb, p53, WT-1, p16(INK4a), BRCA-1,
BRCA-2
CANCER SUPPRESSOR GENES
TUMSO3O3O9 75
The central role of the pRB in regulating the cell cycle
TUMSO3O3O9 76
Selected tumor-suppressor gene involved in human neoplasm
TGF-β receptor
• Function: Growth inhibition
• Tumors associated with somatic mutation:
TUMSO3O3O9 77
• Tumors associated with somatic mutation:Carcinoma of colon
• Tumors associated with inherited mutation:Unknown
Selected tumor-suppressor gene involved in human neoplasm
E-cadherin
• Function:
Cell adhesion
• Tumors associated with somatic mutation:
TUMSO3O3O9 78
• Tumors associated with somatic mutation:
Ca. gaster & breast
• Tumors associated with inherited mutation:
Familial gastric cancer
Selected tumor-suppressor gene involved in human neoplasm
NF-1
• Function:
Inhibition of ras signal transduction
• Tumors associated with somatic mutation:
Schwannoma
TUMSO3O3O9 79
Schwannoma
• Tumors associated with inherited mutation:
Neurofibromatosis type 1 and sarcomas
Selected tumor-suppressor gene involved in human neoplasm
NF-2
• Function:
Unknown
• Tumors associated with somatic mutation:
Schwannoma and meningioma
TUMSO3O3O9 80
Schwannoma and meningioma
• Tumors associated with inherited mutation:
Neurofibromatosis type 2,
acoustic schwannoma & meningioma
Selected tumor-suppressor gene involved in human neoplasm
APC
• Function:
Inhibition of signal transduction
• Tumors associated with somatic mutation:
Ca. of stomach, colon, pancreas;
TUMSO3O3O9 81
Ca. of stomach, colon, pancreas; melanoma
• Tumors associated with inherited mutation:
Familial Adenomatous Polyposis coli;
colon cancer
Selected tumor-suppressor gene involved in human neoplasm
Rb• Function:
Regulation of cell cycle
• Tumors associated with somatic mutation:
Retinoblastoma, osteosarcoma,
TUMSO3O3O9 82
Retinoblastoma, osteosarcoma,
Ca breast, colon, lung
• Tumors associated with inherited mutation:
Retinoblastoma, osteosarcoma
Selected tumor-suppressor gene involved in human neoplasm
p53
• Function:Regulation of cell cycle & apoptosis
in responseto DNA damage
• Tumors associated with somatic mutation:
TUMSO3O3O9 83
• Tumors associated with somatic mutation:Ca. gaster & breast
• Tumors associated with inherited mutation:Li-Fraumeni syndromeMultiple carcinoma and sarcoma
Selected tumor-suppressor gene involved in human neoplasm
WT-1• Function:
Nuclear transcription
• Tumors associated with somatic mutation:
TUMSO3O3O9 84
• Tumors associated with somatic mutation:
Wilms tumor
• Tumors associated with inherited mutation:
Wilms tumor
Selected tumor-suppressor gene involved in human neoplasm
p16(INK-4a)• Function:
Regulation of cell cycle by inhibiting CDK
TUMSO3O3O9 85
CDK
• Tumors associated with somatic mutation:
Pancreatic, esophageal cancer
• Tumors associated with inherited mutation:
Melanoma
Selected tumor-suppressor gene involved in human neoplasm
BRCA-1
• Function:
DNA repair
• Tumors associated with somatic mutation:
TUMSO3O3O9 86
• Tumors associated with somatic mutation:
Unknown
• Tumors associated with inherited mutation:
Ca of female breast and ovary
Selected tumor-suppressor gene involved in human neoplasm
BRCA-2
• Function:
DNA repair
• Tumors associated with somatic mutation:
TUMSO3O3O9 87
• Tumors associated with somatic mutation:
Unknown
• Tumors associated with inherited mutation:
Ca of male and female breast
The role of p53 in maintaining the integrity of the genome
TUMSO3O3O9 88
Apoptosis(programmed cell death)
Internally programmed and coordinated death / loss of single cells spread among healthy cells,
in a form of cell death designed to eliminate unwanted
TUMSO3O3O9 89
in a form of cell death designed to eliminate unwanted cells,
through the serial event activities,
by a set of responsible gene product.
Genes that Regulate Apoptosis
bcl-2 family:
Antagonists
bcl-2 and bcl-xL
TUMSO3O3O9 90
bcl-2 and bcl-xL
Agonists
bax, bcl-xS, bad, bid
Regulation of cell death
TUMSO3O3O9 91
Biological Mechanism
1. Signaling pathways apoptosis initiation
2. Control and integration balance between negative regulatory molecule
TUMSO3O3O9 92
(inhibit) and positive (stimulate)
3. Common-execution phase actual death program accomplished largely by caspase family protease
4. Removal of death cells by phagocytosis
APOPTOSIS
TUMSO3O3O9 93
Promotion of Carcinogenesis
• Promoters: phorbol esters, hormone, phenols, drugs
• Not mutagenic how do they contribute to tumorigenesis study of TPA
• TPA: - phorbol esters
- powerful activator for protein kinase C, an
TUMSO3O3O9 94
- powerful activator for protein kinase C, an
enzyme that phophrylates several substrates
involved in signal transduction pathways
Initiation&
Promotion
TUMSO3O3O9 95
Initiation & promotion
TUMSO3O3O9 96
Radiation Carcinogenesis
• Transform all kind of cells in vitro and induce neoplasms in vivo, in human & experimental animal
• UV light skin cancer
• Ionizing radiation of medical, occupational, and bomb of
TUMSO3O3O9 97
• Ionizing radiation of medical, occupational, and bomb of origins produce a variety of malignant neoplasms
• The effect of UV light is somewhat differ from those of ionizing radiation
Hierarchy of Vulnerability1. Leukemia
2. Thyroid
3. Breast, lung, salivary gland (intermediate)
TUMSO3O3O9 98
(intermediate)
4. Skin, bone, gastrointestinal tract (relatively resistant)
Sifat dasar transformasi sel
1. Pemenuhan kebutuhan sendiri signal pertumbuhan
2. Insensitif terhadap signal inhibisi
3. Kemampuan mengelak dari aapoptosis
TUMSO3O3O9 99
3. Kemampuan mengelak dari aapoptosis
4. Kehilangan kemampuan reparasi DNA
5. Potensi replikasi tak terbatas
6. Kemampuan angiogenesis terus menerus
7. Kemampuan invasi dan metastasis
8. Melepaskan diri dari imunitas dan rejeksi